CD200 binds to its cognate receptor, CD200R, which is highly expressed in the tumor microenvironment (TME) on TAMCs, including tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), and tumor-associated dendritic cells (TADCs) [8]. The gene discussed is CD200; the disease is neoplasm.